Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis

Published:2020-10-28 Issue:4 Volume:80 Page:543-545
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Ding Yuchuan,Huang Baozhen,Wang Yuan,Hou Jun,Chi Ying,Zhou Zhixuan,Li Jianguo^ORCID

Funder

Beijing Municipal Administration of Hospitals Clinical Medicine Development of special funding support

the Capital’s Funds for Health Improvement and Research

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. Polymyositis and Dermatomyositis

2. Consensus-based recommendations for the management of juvenile dermatomyositis

3. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

4. Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

5. A child with severe juvenile dermatomyositis treated with ruxolitinib;Aeschlimann;Brain,2018

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK Inhibitors - Pros and Cons Learned from Their Use in Rheumatic Diseases;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-08-20

2. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons;Expert Opinion on Pharmacotherapy;2024-08-12

3. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07

4. Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients;Journal of Autoimmunity;2024-06

5. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature;Seminars in Arthritis and Rheumatism;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3